Investor · Belmont, MA

Michael Gilman

Open Michael in the network graph →

Filings

13

SEC Form D

Connections

60

co-filers

Capital

$168.5M

across filings

Active

Nov 2010

to Oct 2022

Most-connected co-filers (60)

Alan E. Walts · Cambridge, MA4 shared Paula Ragan · CAMBRIDGE, MA3 shared Colleen Cuffaro · Waltham, MA2 shared Paula Ragan · Belmont, MA2 shared Nagesh Mahanthappa · Cambridge, MA2 shared David M. Neafus · Cambridge, MA2 shared Isaac Blech · Cambridge, MA2 shared Travis Farese · Austin, TX2 shared Amir Nashat · San Diego, CA2 shared Peter Barrett · Cambridge, MA2 shared Raj Parekh · Santa Monica, CA2 shared Kristina Burow · Ann Arbor, MI2 shared Timothy Springer · Cambridge, MA2 shared Todd Slattery · New York, NY1 shared Timothy J. Mccunn · Gatineau, Quebec, Canada1 shared Justin C. Bertram · Pittsburgh, PA1 shared Paul J. Smith · Gatineau, Quebec, Canada1 shared Hugh J. Notman · Gatineau, Quebec, Canada1 shared John Celebi · Burlingame, CA1 shared Thomas Neyarapally · CAMBRIDGE, MA1 shared RAI Capital Management LLC · Austin, TX1 shared Elan R. Ezickson · Radnor, PA1 shared Cross Mountain Capital Management LLC · Colorado Springs, CO1 shared Steven Archambault · Gatineau, Quebec, Canada1 shared

Recent filings (13)

Cross Mountain Capital Multifamily Alpha Fund LLCOct 2022 · 1 co-filer$10.0M Cross Mountain Capital Multifamily Alpha Fund LLCOct 2022 · 1 co-filer$10.0M 6980 Stuart St, LLCApr 2022 · 3 co-filers$4.7M 6980 Stuart St, LLCApr 2022 · 3 co-filers$4.7M 2660 Ingalls St, LLCFeb 2021 · 7 co-filers 2660 Ingalls St, LLCFeb 2021 · 7 co-filers Arrakis Therapeutics, Inc.Apr 2019 · 11 co-filers$75.0M Arrakis Therapeutics, Inc.Apr 2019 · 11 co-filers$75.0M Scholar Rock Holding CorpJan 2018 · 19 co-filers$47.0M Obsidian Therapeutics, Inc.Dec 2017 · 11 co-filers$49.9M Obsidian Therapeutics, Inc.Dec 2017 · 11 co-filers$49.9M X4 Pharmaceuticals, Inc.Nov 2017 · 19 co-filers$30.0M Arrakis Therapeutics, Inc.Mar 2017 · 13 co-filers$41.2M Arrakis Therapeutics, Inc.Mar 2017 · 13 co-filers$41.2M Scholar Rock LLCJan 2016 · 12 co-filers$40.0M Scholar Rock LLCJan 2016 · 12 co-filers$40.0M X4 Pharmaceuticals, Inc.Aug 2015 · 12 co-filers$37.5M X4 Pharmaceuticals, Inc.Aug 2015 · 12 co-filers$37.5M X4 Pharmaceuticals, Inc.Jan 2015 · 7 co-filers$1.2M X4 Pharmaceuticals, Inc.Jan 2015 · 7 co-filers$1.2M Stromedix IncJan 2011 · 8 co-filers$15.5M Stromedix IncJan 2011 · 8 co-filers$15.5M GENE NETWORK SCIENCES, INC.Nov 2010 · 10 co-filers GENE NETWORK SCIENCES, INC.Nov 2010 · 10 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Michael in the interactive graph →